| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +1394.47% |
| VRNA | Verona Pharma Plc | $77.75B | +945.59% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +777.98% |
| ARGX | Argen X SE | $54.32B | +630.57% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +426.30% |
| ONC | BeiGene Ltd | $34.73B | +367.10% |
| RVMD | Revolution Medicines Inc | $30.63B | +311.89% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +217.03% |
| BNTX | BioNTech SE | $23.52B | +216.29% |
| INSM | Insmed Inc | $23.04B | +209.83% |
| ROIV | Roivant Sciences Ltd | $21.31B | +186.56% |
| INCY | Incyte Corp | $19.46B | +161.75% |
| MRNA | Moderna Inc | $18.90B | +154.19% |
| GMAB | Genmab | $17.06B | +129.37% |
| ASND | Ascendis Pharma A/S | $15.18B | +104.14% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +97.76% |
| SMMT | Summit Therapeutics Inc | $13.47B | +81.17% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +74.87% |
| EXEL | Exelixis Inc | $12.69B | +70.70% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +70.66% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +63.51% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +62.18% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +49.33% |
| ABVX | Abivax | $10.29B | +38.34% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +36.14% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +33.81% |
| CYTK | Cytokinetics Inc | $9.51B | +27.90% |
| KRYS | Krystal Biotech Inc | $9.03B | +21.39% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +13.61% |
| IBRX | ImmunityBio Inc | $8.26B | +11.13% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +9.43% |
| TECH | Bio-Techne Corp | $7.53B | +1.22% |
| MTSR | Metsera Inc | $7.40B | -0.42% |
| PCVX | Vaxcyte Inc | $7.36B | -0.98% |
| MRUS | Merus N.V | $6.83B | -8.20% |
| IMVT | Immunovant Inc | $6.81B | -8.37% |
| KYMR | Kymera Therapeutics Inc | $6.71B | -9.70% |
| ACLX | Arcellx Inc | $6.67B | -10.35% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | -11.72% |
| CDTX | Cidara Therapeutics Inc | $6.49B | -12.66% |
| CELC | Celcuity Inc | $6.48B | -12.89% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | -15.85% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | -17.24% |
| SRRK | Scholar Rock Holding Corp | $6.03B | -18.89% |
| TGTX | TG Therapeutics Inc | $6.00B | -19.29% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | -20.01% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | -20.25% |
| COGT | Cogent Biosciences Inc | $5.89B | -20.74% |
| PTCT | PTC Therapeutics Inc | $5.86B | -21.24% |
| APGE | Apogee Therapeutics Inc | $5.82B | -21.70% |
| SYRE | Spyre Therapeutics Inc | $5.72B | -23.12% |
| BLTE | Belite Bio Inc | $5.59B | -24.83% |
| CGON | Cg Oncology Inc | $5.35B | -28.04% |
| LEGN | Legend Biotech Corp | $5.26B | -29.20% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | -29.41% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | -29.96% |
| CRSP | CRISPR Therapeutics AG | $5.16B | -30.61% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | -36.38% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | -36.46% |
| FOLD | Amicus Therapeutics Inc | $4.50B | -39.42% |
| TVTX | Travere Therapeutics Inc | $4.41B | -40.65% |
| AKRO | Akero Therapeutics Inc | $4.38B | -41.09% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | -41.54% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | -42.65% |
| ERAS | Erasca Inc | $3.88B | -47.88% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | -47.89% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | -48.54% |
| VKTX | Viking Therapeutics Inc | $3.67B | -50.65% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | -51.24% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | -51.52% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | -55.62% |
| BEAM | Beam Therapeutics Inc | $3.28B | -55.94% |
| DNLI | Denali Therapeutics Inc | $3.21B | -56.88% |
| RCUS | Arcus Biosciences Inc | $3.01B | -59.54% |
| DYN | Dyne Therapeutics Inc | $3.00B | -59.65% |
| ORKA | ARCA biopharma Inc | $2.91B | -60.88% |
| TNGX | Tango Therapeutics Inc | $2.83B | -61.90% |
| GPCR | Structure Therapeutics Inc | $2.81B | -62.21% |
| SLNO | Soleno Therapeutics Inc | $2.74B | -63.13% |
| RLAY | Relay Therapeutics Inc | $2.73B | -63.28% |
| ALMS | Alumis Inc | $2.67B | -64.13% |
| IRON | Disc Medicine Inc | $2.66B | -64.17% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | -64.43% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | -65.25% |
| IDYA | Ideaya Biosciences Inc | $2.57B | -65.40% |
| ELVN | Enliven Therapeutics Inc | $2.52B | -66.09% |
| IMNM | Immunome Inc | $2.50B | -66.35% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | -66.72% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | -67.06% |
| ETNB | 89bio Inc | $2.34B | -68.49% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | -69.08% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | -70.18% |
| KOD | Kodiak Sciences Inc | $2.18B | -70.67% |
| CLDX | Celldex Therapeutics Inc | $2.11B | -71.67% |
| ZLAB | Zai Lab Ltd | $2.08B | -72.09% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | -72.67% |
| MESO | Mesoblast Ltd | $2.02B | -72.86% |
| TYRA | Tyra Biosciences Inc | $1.97B | -73.47% |
| SION | Sionna Therapeutics Inc | $1.96B | -73.67% |
| STOK | Stoke Therapeutics Inc | $1.96B | -73.68% |
| NBTX | Nanobiotix | $1.94B | -73.95% |
| AAPG | Ascentage Pharma Group International | $1.93B | -74.01% |
| PHVS | Pharvaris NV | $1.92B | -74.12% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | -74.25% |
| GLPG | Galapagos NV | $1.90B | -74.47% |
| RAPP | Rapport Therapeutics Inc | $1.89B | -74.60% |
| OCUL | Ocular Therapeutix Inc | $1.87B | -74.86% |
| TRVI | Trevi Therapeutics Inc | $1.86B | -75.05% |
| ADMA | Adma Biologics Inc | $1.84B | -75.26% |
| NVAX | Novavax Inc | $1.82B | -75.48% |
| ZYME | Zymeworks BC Inc | $1.81B | -75.63% |
| NRIX | Nurix Therapeutics Inc | $1.81B | -75.71% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | -76.06% |
| VRDN | Viridian Therapeutics Inc | $1.77B | -76.22% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | -76.32% |
| VCEL | Vericel Corp | $1.75B | -76.49% |
| OCS | Oculis Holding AG | $1.74B | -76.54% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | -76.65% |
| BHVN | Biohaven Ltd | $1.70B | -77.15% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | -77.16% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | -77.38% |
| CAPR | Capricor Therapeutics Inc | $1.68B | -77.40% |
| ANAB | AnaptysBio Inc | $1.67B | -77.48% |
| PVLA | Palvella Therapeutics Inc | $1.66B | -77.62% |
| ABCL | AbCellera Biologics Inc | $1.65B | -77.76% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | -77.79% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | -77.91% |
| INVA | Innoviva Inc | $1.63B | -78.03% |
| NTLA | Intellia Therapeutics Inc | $1.62B | -78.23% |
| NKTR | Nektar Therapeutics | $1.62B | -78.24% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | -78.26% |
| QURE | uniQure N.V. | $1.59B | -78.66% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | -78.76% |
| RAPT | RAPT Therapeutics Inc | $1.56B | -78.96% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | -79.08% |
| PGEN | Precigen Inc | $1.55B | -79.13% |
| IMTX | Immatics N.V | $1.53B | -79.38% |
| ARDX | Ardelyx Inc | $1.52B | -79.51% |
| MBX | MBX Biosciences Inc | $1.52B | -79.60% |
| INBX | Inhibrx Biosciences Inc | $1.50B | -79.77% |
| VIR | Vir Biotechnology Inc | $1.47B | -80.27% |
| IMCR | Immunocore Holdings plc | $1.45B | -80.50% |
| URGN | UroGen Pharma Ltd | $1.43B | -80.79% |
| BCAX | Bicara Therapeutics Inc | $1.41B | -80.98% |
| GHRS | GH Research PLC | $1.39B | -81.35% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | -81.54% |
| SEPN | Septerna Inc | $1.34B | -82.01% |
| MPLT | MapLight Therapeutics Inc | $1.34B | -82.03% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | -82.35% |
| MAZE | Maze Therapeutics Inc | $1.30B | -82.58% |
| FTRE | FORTE SOFTWARE INC | $1.27B | -82.93% |
| AVBP | ArriVent BioPharma Inc | $1.24B | -83.26% |
| TRML | Tourmaline Bio Inc | $1.24B | -83.38% |
| WVE | Wave Life Sciences Ltd | $1.22B | -83.60% |
| ZBIO | Zenas Biopharma Inc | $1.13B | -84.82% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | -84.84% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | -85.23% |
| MNKD | Mannkind Corp | $1.10B | -85.25% |
| DBVT | DBV Technologies | $1.10B | -85.27% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | -85.38% |
| SVRA | Savara Inc | $1.07B | -85.64% |
| JBIO | Jade Biosciences Inc | $1.06B | -85.73% |
| CVAC | CureVac N.V. | $1.05B | -85.89% |
| ANNX | Annexon Inc | $1.05B | -85.92% |
| VTYX | Ventyx Biosciences Inc | $998.72M | -86.57% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | -86.69% |
| CGEM | Cullinan Oncology Inc | $953.73M | -87.17% |
| PHAR | Pharming Group N.V. | $940.58M | -87.35% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | -87.58% |
| ABUS | Arbutus Biopharma Corp | $913.84M | -87.71% |
| KURA | Kura Oncology Inc | $908.93M | -87.78% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | -87.82% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | -88.06% |
| JANX | Janux Therapeutics Inc | $878.90M | -88.18% |
| XNCR | Xencor Inc | $868.03M | -88.33% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | -88.53% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | -88.65% |
| GERN | Geron Corp | $843.41M | -88.66% |
| EVMN | Evommune Inc | $841.03M | -88.69% |
| VOR | Vor Biopharma Inc | $840.96M | -88.69% |
| TBPH | Theravance Biopharma Inc | $837.63M | -88.74% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | -88.77% |
| SANA | Sana Biotechnology Inc | $825.64M | -88.90% |
| MGTX | MeiraGTx Holdings plc | $805.50M | -89.17% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | -89.28% |
| OMER | Omeros Corporation | $797.02M | -89.28% |
| ABSI | Absci Corp | $789.28M | -89.39% |
| CMRX | Chimerix Inc | $766.03M | -89.70% |
| RLMD | Relmada Therapeutics Inc | $761.50M | -89.76% |
| ANRO | Alto Neuroscience Inc | $714.55M | -90.39% |
| ATXS | Astria Therapeutics Inc | $709.95M | -90.45% |
| DSGN | Design Therapeutics Inc | $693.10M | -90.68% |
| SLDB | Solid Biosciences Inc | $690.73M | -90.71% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | -90.81% |
| CTMX | CytomX Therapeutics Inc | $675.41M | -90.92% |
| CRMD | CorMedix Inc | $663.22M | -91.08% |
| IVA | Inventiva | $655.21M | -91.19% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | -91.29% |
| CABA | Cabaletta Bio Inc | $640.38M | -91.39% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | -91.40% |
| PRME | Prime Medicine Inc | $596.03M | -91.98% |
| CADL | Candel Therapeutics Inc | $589.73M | -92.07% |
| CBIO | Crescent Biopharma Inc | $573.22M | -92.29% |
| TECX | AvroBio Inc | $573.01M | -92.29% |
| CLYM | Eliem Therapeutics Inc | $571.31M | -92.32% |
| ARVN | Arvinas Inc | $570.83M | -92.32% |
| ALLO | Allogene Therapeutics Inc | $550.84M | -92.59% |
| VALN | Valneva SE | $545.52M | -92.66% |
| RIGL | Rigel Pharmaceuticals | $542.79M | -92.70% |
| GYRE | Gyre Therapeutics Inc | $540.72M | -92.73% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | -92.76% |
| MDXG | Mimedx Group Inc | $537.64M | -92.77% |
| PRTA | Prothena Corporation plc | $532.36M | -92.84% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | -93.01% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | -93.25% |
| XOMA | XOMA Corp | $497.12M | -93.31% |
| STRO | Sutro Biopharma Inc | $491.87M | -93.39% |
| OCGN | Ocugen Inc | $466.88M | -93.72% |
| SVA | Sinovac Biotech Ltd | $464.94M | -93.75% |
| IMMX | Immix Biopharma Inc | $462.80M | -93.78% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | -93.78% |
| STTK | Shattuck Labs Inc | $458.03M | -93.84% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | -93.93% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | -93.93% |
| UPB | Upstream Bio Inc | $449.51M | -93.95% |
| AUTL | Autolus Therapeutics plc | $447.12M | -93.99% |
| ADCT | Adc Therapeutics SA | $438.08M | -94.11% |
| ASMB | Assembly Biosciences Inc | $435.45M | -94.14% |
| MNPR | Monopar Therapeutics Inc | $432.42M | -94.18% |
| AURA | Aura Biosciences Inc | $430.49M | -94.21% |
| OVID | Ovid Therapeutics Inc | $424.86M | -94.29% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | -94.36% |
| IPSC | Century Therapeutics Inc | $415.14M | -94.42% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | -94.50% |
| CMPX | Compass Therapeutics Inc | $408.80M | -94.50% |
| CYBN | Cybin Inc | $408.43M | -94.51% |
| AVTX | Avalo Therapeutics Inc | $403.76M | -94.57% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | -94.58% |
| BNTC | Benitec Biopharma Inc | $398.51M | -94.64% |
| LYEL | Lyell Immunopharma Inc | $390.28M | -94.75% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | -94.75% |
| CCCC | C4 Therapeutics Inc | $389.10M | -94.77% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | -94.78% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | -94.84% |
| RVNC | Revance Therapeutics Inc | $380.38M | -94.88% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | -94.89% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | -94.93% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | -94.93% |
| OABI | OmniAb Inc | $374.99M | -94.96% |
| REPL | Replimune Group Inc | $374.27M | -94.97% |
| ALT | Altimmune Inc | $373.67M | -94.97% |
| VSTM | Verastem Inc | $373.33M | -94.98% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | -94.98% |
| PBYI | Puma Biotechnology Inc | $371.93M | -95.00% |
| LRMR | Larimar Therapeutics Inc | $365.67M | -95.08% |
| CLLS | Cellectis | $364.91M | -95.09% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | -95.10% |
| EDIT | Editas Medicine Inc | $349.39M | -95.30% |
| PALI | Palisade Bio Inc | $346.56M | -95.34% |
| RGNX | Regenxbio Inc | $345.32M | -95.36% |
| IMRX | Immuneering Corp Class A | $344.95M | -95.36% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | -95.37% |
| PRLD | Prelude Therapeutics Inc | $343.28M | -95.38% |
| FBRX | Forte Biosciences Inc | $340.15M | -95.43% |
| IMAB | I-Mab | $339.64M | -95.43% |
| NMRA | Neumora Therapeutics Inc | $334.56M | -95.50% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | -95.58% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | -95.61% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | -95.61% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | -95.63% |
| ABEO | Abeona Therapeutics Inc | $323.57M | -95.65% |
| SLN | Silence Therapeutics Plc | $321.20M | -95.68% |
| RZLT | Rezolute Inc | $319.69M | -95.70% |
| IVVD | Invivyd Inc | $319.57M | -95.70% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | -95.72% |
| ANL | Adlai Nortye Ltd | $317.46M | -95.73% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | -95.90% |
| SCPH | scPharmaceuticals Inc | $304.59M | -95.90% |
| NAGE | Niagen Bioscience Inc | $304.32M | -95.91% |
| SRZN | Surrozen Inc | $304.03M | -95.91% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | -95.93% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | -96.02% |
| IRD | Ocuphire Pharma Inc | $295.61M | -96.02% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | -96.11% |
| ACIU | AC Immune SA | $289.11M | -96.11% |
| TENX | Tenax Therapeutics Inc | $288.39M | -96.12% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | -96.15% |
| YDES | YD Bio Ltd | $278.91M | -96.25% |
| MGNX | Macrogenics Inc | $278.39M | -96.26% |
| FATE | Fate Therapeutics Inc | $275.57M | -96.29% |
| CNTX | Context Therapeutics Inc | $273.80M | -96.32% |
| SABS | SAB Biotherapeutics Inc | $272.68M | -96.33% |
| NVCT | Nuvectis Pharma Inc | $269.23M | -96.38% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | -96.45% |
| TARA | Protara Therapeutics Inc | $262.06M | -96.48% |
| CGEN | Compugen Ltd | $260.97M | -96.49% |
| TRDA | Entrada Therapeutics Inc | $257.38M | -96.54% |
| CHRS | Coherus Biosciences Inc | $256.00M | -96.56% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | -96.56% |
| HUMA | Humacyte Inc | $255.32M | -96.57% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | -96.63% |
| ALEC | Alector Inc | $245.37M | -96.70% |
| LENZ | LENZ Therapeutics Inc | $242.37M | -96.74% |
| THRD | Third Harmonic Bio Inc | $241.86M | -96.75% |
| CDXS | Codexis Inc | $239.96M | -96.77% |
| VYGR | Voyager Therapeutics Inc | $237.02M | -96.81% |
| ADAG | Adagene Inc | $236.93M | -96.81% |
| NKTX | Nkarta Inc | $236.88M | -96.81% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | -96.87% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | -96.89% |
| NERV | Minerva Neurosciences Inc | $230.61M | -96.90% |
| SLRN | Acelyrin Inc | $228.54M | -96.93% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | -96.97% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | -96.98% |
| CRBU | Caribou Biosciences Inc | $223.96M | -96.99% |
| KROS | Keros Therapeutics Inc | $223.18M | -97.00% |
| RNA | Atrium Therapeutics Inc | $222.37M | -97.01% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | -97.06% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | -97.07% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | -97.24% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | -97.28% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | -97.29% |
| ELTX | Elicio Therapeutics Inc | $200.75M | -97.30% |
| KRRO | Korro Bio Inc | $198.45M | -97.33% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | -97.34% |
| DTIL | Precision Biosciences Inc | $195.87M | -97.37% |
| IMUX | Immunic Inc | $190.70M | -97.44% |
| QTTB | Q32 Bio Inc | $187.99M | -97.47% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | -97.50% |
| MDWD | MediWound Ltd | $184.49M | -97.52% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | -97.53% |
| THAR | Tharimmune Inc | $183.00M | -97.54% |
| IFRX | InflaRx N.V. | $182.18M | -97.55% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | -97.57% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | -97.60% |
| GALT | Galectin Therapeutics Inc | $177.81M | -97.61% |
| ACHV | Achieve Life Sciences Inc | $173.54M | -97.67% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | -97.68% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | -97.68% |
| HRTX | Heron Therapeutics Inc | $172.54M | -97.68% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | -97.69% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | -97.70% |
| SPRO | Spero Therapeutics Inc | $169.62M | -97.72% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | -97.72% |
| THTX | Theratechnologies Inc | $167.34M | -97.75% |
| ANTX | AN2 Therapeutics Inc | $166.61M | -97.76% |
| EQ | Equillium Inc | $166.29M | -97.76% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | -97.78% |
| PRQR | ProQR Therapeutics N.V | $164.37M | -97.79% |
| MENS | Jyong Biotech Ltd | $164.22M | -97.79% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | -97.81% |
| IPHA | Innate Pharma | $159.97M | -97.85% |
| TTRX | Turn Therapeutics Inc | $157.58M | -97.88% |
| MOLN | Molecular Partners AG | $154.89M | -97.92% |
| VXRT | Vaxart Inc | $153.61M | -97.93% |
| HURA | TuHURA Biosciences Inc | $151.32M | -97.97% |
| NBP | NovaBridge Biosciences. | $150.91M | -97.97% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | -97.98% |
| AKTX | Akari Therapeutics Plc | $148.12M | -98.01% |
| MRSN | Mersana Therapeutics Inc | $145.36M | -98.05% |
| INDP | Indaptus Therapeutics Inc | $143.82M | -98.07% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | -98.07% |
| PROK | ProKidney Corp - Class A | $137.85M | -98.15% |
| TCRX | Tscan Therapeutics Inc | $137.63M | -98.15% |
| GNLX | Genelux Corp | $137.21M | -98.15% |
| GUTS | Fractyl Health Inc | $136.31M | -98.17% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | -98.22% |
| AGEN | Agenus Inc | $131.36M | -98.23% |
| ACOG | Alpha Cognition Inc | $124.77M | -98.32% |
| CRDF | Cardiff Oncology Inc | $123.75M | -98.34% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | -98.38% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | -98.39% |
| SEER | Seer Inc - Class A | $115.64M | -98.44% |
| ENGN | enGene Holdings Inc | $115.22M | -98.45% |
| RPTX | Repare Therapeutics Inc | $113.91M | -98.47% |
| PYXS | Pyxis Oncology Inc | $108.70M | -98.54% |
| VANI | Vivani Medical Inc | $108.35M | -98.54% |
| CGTX | Cognition Therapeutics Inc | $106.33M | -98.57% |
| HLVX | HilleVax Inc | $104.74M | -98.59% |
| ONCY | Oncolytics Biotech Inc | $104.52M | -98.59% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | -98.60% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | -98.61% |
| PEPG | PepGen Inc | $103.13M | -98.61% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | -98.62% |
| BMEA | Biomea Fusion Inc | $98.33M | -98.68% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | -98.68% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | -98.69% |
| ICCC | Immucell Corp | $96.17M | -98.71% |
| PMN | ProMIS Neurosciences Inc | $93.94M | -98.74% |
| ATHA | Athira Pharma Inc | $92.15M | -98.76% |
| FBIO | Fortress Biotech Inc | $91.60M | -98.77% |
| PTHS | Channel Therapeutics Corporation | $90.85M | -98.78% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | -98.79% |
| ANIX | Anixa Biosciences Inc | $88.68M | -98.81% |
| EXOZ | Invizyne Technologies Inc | $88.10M | -98.82% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | -98.83% |
| AARD | Aardvark Therapeutics Inc | $87.05M | -98.83% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | -98.83% |
| PYPD | Polypid Ltd | $86.83M | -98.83% |
| NRXS | Neuraxis Inc | $85.30M | -98.85% |
| LPTX | Leap Therapeutics Inc | $84.76M | -98.86% |
| CSBR | Champions Oncology Inc | $82.35M | -98.89% |
| ACET | Adicet Bio Inc | $81.58M | -98.90% |
| HYFT | MindWalk Holdings Corp | $79.54M | -98.93% |
| MAIA | MAIA Biotechnology Inc | $79.48M | -98.93% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | -98.95% |
| FBIOP | Fortress Biotech Inc | $77.72M | -98.95% |
| RLYB | Rallybio Corp | $76.87M | -98.97% |
| PLRX | Pliant Therapeutics Inc | $76.77M | -98.97% |
| GANX | Gain Therapeutics Inc | $75.20M | -98.99% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | -99.00% |
| XBIT | XBiotech Inc | $74.39M | -99.00% |
| OSTX | OS Therapies Inc | $74.24M | -99.00% |
| MCRB | Seres Therapeutics Inc | $73.19M | -99.02% |
| SAVA | Cassava Sciences Inc. | $72.46M | -99.03% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | -99.03% |
| EDSA | Edesa Biotech Inc | $70.82M | -99.05% |
| BYSI | BeyondSpring Inc | $70.31M | -99.05% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | -99.08% |
| SPRB | Spruce Biosciences Inc | $67.96M | -99.09% |
| CUE | Cue Biopharma Inc | $66.52M | -99.11% |
| IMA | Ikena Oncology Inc | $66.48M | -99.11% |
| MNOV | Medicinova Inc | $65.46M | -99.12% |
| IBIO | iBio Inc | $64.94M | -99.13% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | -99.14% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | -99.14% |
| IMMP | Immutep Ltd | $63.92M | -99.14% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | -99.15% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | -99.15% |
| ACHL | Achilles Therapeutics Plc | $63.22M | -99.15% |
| PDSB | PDS Biotechnology Corporation | $61.96M | -99.17% |
| OTLK | Outlook Therapeutics Inc | $61.25M | -99.18% |
| GLTO | Galecto Inc | $60.81M | -99.18% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | -99.20% |
| ANVS | Annovis Bio Inc | $57.22M | -99.23% |
| DWTX | Virios Therapeutics Inc | $57.12M | -99.23% |
| ENTX | Entera Bio Ltd | $55.48M | -99.25% |
| TIL | Instil Bio Inc | $55.21M | -99.26% |
| KZR | Kezar Life Sciences Inc | $53.76M | -99.28% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | -99.29% |
| MREO | Mereo Biopharma Group Plc | $52.71M | -99.29% |
| NBY | Stablecoin Development Corp | $52.10M | -99.30% |
| RNTX | Rein Therapeutics Inc | $51.79M | -99.30% |
| GOSS | Gossamer Bio Inc | $51.14M | -99.31% |
| MGX | Metagenomi Inc | $50.82M | -99.32% |
| ACTU | Actuate Therapeutics Inc | $50.03M | -99.33% |
| INKT | MiNK Therapeutics Inc | $48.84M | -99.34% |
| ESLA | Estrella Immunopharma Inc | $48.44M | -99.35% |
| XLO | Xilio Therapeutics Inc | $48.23M | -99.35% |
| CING | Cingulate Inc | $47.16M | -99.37% |
| ATYR | Atyr Pharma Inc | $46.89M | -99.37% |
| LVTX | LAVA Therapeutics NV | $45.77M | -99.38% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | -99.39% |
| PSTV | Plus Therapeutics Inc | $45.56M | -99.39% |
| ATOS | Atossa Therapeutics Inc | $44.09M | -99.41% |
| KALA | Kala Bio Inc | $43.31M | -99.42% |
| RNXT | RenovoRx Inc | $41.96M | -99.44% |
| NTRB | Nutriband Inc | $41.39M | -99.44% |
| HYPD | Eyenovia Inc | $41.14M | -99.45% |
| FGEN | FibroGen Inc | $39.31M | -99.47% |
| NNVC | NanoViricides Inc | $37.88M | -99.49% |
| VERU | Veru Inc | $37.40M | -99.50% |
| LTRN | Lantern Pharma Inc | $37.25M | -99.50% |
| INMB | INmune Bio Inc | $37.22M | -99.50% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | -99.51% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | -99.51% |
| GRCE | Acasti Pharma Inc | $36.05M | -99.52% |
| GBIO | Generation Bio Company | $35.97M | -99.52% |
| ABVC | ABVC BioPharma Inc | $35.82M | -99.52% |
| MURA | Mural Oncology plc | $35.34M | -99.52% |
| LITS | Lite Strategy Inc | $35.16M | -99.53% |
| ALGS | Aligos Therapeutics Inc | $34.65M | -99.53% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | -99.54% |
| DARE | Dare Bioscience Inc | $33.92M | -99.54% |
| EVAX | Evaxion Biotech A/S | $33.82M | -99.55% |
| BOLD | Boundless Bio Inc | $32.94M | -99.56% |
| SNTI | Senti Biosciences Inc | $31.46M | -99.58% |
| TVRD | Cara Therapeutics Inc | $30.96M | -99.58% |
| LSTA | Lisata Therapeutics Inc | $30.05M | -99.60% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | -99.60% |
| APLM | Apollomics Inc - Class A | $29.93M | -99.60% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | -99.61% |
| SKYE | Skye Bioscience Inc | $29.10M | -99.61% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | -99.61% |
| GRDX | Entero Therapeutics Inc | $28.95M | -99.61% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | -99.62% |
| CRVO | CervoMed Inc | $28.15M | -99.62% |
| IGC | IGC Pharma Inc | $28.00M | -99.62% |
| DYAI | Dyadic International Inc DE | $27.40M | -99.63% |
| ALLR | Allarity Therapeutics Inc | $27.37M | -99.63% |
| SER | AgeX Therapeutics Inc | $26.82M | -99.64% |
| PLRZ | Polyrizon Ltd | $26.52M | -99.64% |
| CELU | Celularity Inc - Class A | $26.39M | -99.65% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | -99.65% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | -99.65% |
| PTN | Palatin Technologies Inc | $26.08M | -99.65% |
| TPST | Tempest Therapeutics Inc | $25.68M | -99.65% |
| JSPR | Jasper Therapeutics Inc | $25.26M | -99.66% |
| PLUR | Pluri Inc | $24.62M | -99.67% |
| MRKR | Marker Therapeutics Inc | $24.21M | -99.67% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | -99.68% |
| VYNE | VYNE Therapeutics Inc | $22.68M | -99.70% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | -99.70% |
| HOTH | Hoth Therapeutics Inc | $22.13M | -99.70% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -99.70% |
| NXTC | Nextcure Inc | $21.90M | -99.71% |
| OPT | Opthea Ltd | $21.53M | -99.71% |
| CRIS | Curis Inc | $21.11M | -99.72% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -99.73% |
| LGVN | Longeveron Inc - Class A | $19.70M | -99.74% |
| GNTA | Genenta Science SpA | $19.23M | -99.74% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | -99.74% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | -99.75% |
| XCUR | Exicure Inc | $17.78M | -99.76% |
| INAB | IN8bio Inc | $17.72M | -99.76% |
| PASG | Passage Bio Inc | $17.71M | -99.76% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | -99.77% |
| MTVA | MetaVia Inc | $17.25M | -99.77% |
| LPCN | Lipocine Inc | $17.04M | -99.77% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | -99.78% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | -99.78% |
| HIND | ReShape Lifesciences Inc | $15.72M | -99.79% |
| COCP | Cocrystal Pharma Inc | $15.44M | -99.79% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | -99.79% |
| LEXX | Lexaria Bioscience Corp | $15.24M | -99.80% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -99.80% |
| QNCX | Quince Therapeutics Inc | $14.89M | -99.80% |
| APLT | Applied Therapeutics Inc | $14.86M | -99.80% |
| HOOK | Hookipa Pharma Inc | $14.68M | -99.80% |
| BLRX | Bioline Rx Ltd | $14.66M | -99.80% |
| MBRX | Moleculin Biotech Inc | $14.57M | -99.80% |
| IOBT | IO Biotech Inc | $14.50M | -99.81% |
| ICU | SeaStar Medical Holding Corp | $14.34M | -99.81% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | -99.81% |
| GTBP | GT Biopharma Inc | $13.91M | -99.81% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | -99.82% |
| TOVX | Theriva Biologics Inc | $13.51M | -99.82% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | -99.82% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -99.82% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | -99.83% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | -99.83% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | -99.83% |
| CALC | CalciMedica Inc | $11.72M | -99.84% |
| LNAI | Lunai Bioworks Inc | $11.72M | -99.84% |
| TRAW | Traws Pharma Inc | $11.70M | -99.84% |
| INTS | Intensity Therapeutics Inc | $11.33M | -99.85% |
| BIVI | BioVie Inc - Class A | $11.16M | -99.85% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -99.85% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -99.85% |
| APRE | Aprea Therapeutics Inc | $10.96M | -99.85% |
| KAPA | Kairos Pharma Ltd | $10.68M | -99.86% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -99.86% |
| CVM | Cel-Sci Corp | $10.15M | -99.86% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -99.86% |
| MLEC | Moolec Science SA | $10.06M | -99.86% |
| BCDA | BioCardia Inc | $9.85M | -99.87% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -99.87% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -99.87% |
| SNGX | Soligenix Inc | $9.11M | -99.88% |
| IMNN | Imunon Inc | $9.02M | -99.88% |
| EPIX | Essa Pharma Inc | $8.93M | -99.88% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -99.88% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -99.88% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -99.88% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -99.89% |
| IMRN | Immuron Ltd | $8.36M | -99.89% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -99.89% |
| LIMN | Liminatus Pharma Inc | $8.08M | -99.89% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -99.89% |
| NCNA | NuCana plc | $7.95M | -99.89% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -99.89% |
| SYBX | Synlogic Inc | $7.72M | -99.90% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -99.90% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -99.90% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -99.90% |
| GNPX | Genprex Inc | $7.02M | -99.91% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -99.91% |
| EVGN | Evogene Ltd | $6.91M | -99.91% |
| SILO | SILO Pharma Inc | $6.78M | -99.91% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -99.91% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -99.91% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -99.91% |
| GOVX | Geovax Labs Inc | $6.29M | -99.92% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -99.92% |
| BCAB | BioAtla Inc | $6.19M | -99.92% |
| PPBT | Purple Biotech Ltd | $6.05M | -99.92% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -99.92% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -99.93% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -99.93% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -99.93% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -99.93% |
| HCWB | HCW Biologics Inc | $5.10M | -99.93% |
| PULM | Pulmatrix Inc | $4.97M | -99.93% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -99.93% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -99.93% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -99.94% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -99.94% |
| ALZN | Alzamend Neuro Inc | $4.38M | -99.94% |
| MBIO | Mustang Bio Inc | $4.29M | -99.94% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -99.94% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -99.94% |
| REVB | Revelation Biosciences Inc | $4.26M | -99.94% |
| FBLG | FibroBiologics Inc | $4.23M | -99.94% |
| ENVB | Enveric Biosciences Inc | $4.15M | -99.94% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -99.94% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -99.95% |
| PHGE | BiomX Inc | $3.91M | -99.95% |
| PBM | Psyence Biomedical Ltd | $3.76M | -99.95% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -99.95% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -99.95% |
| VIVS | VivoSim Labs Inc | $3.36M | -99.95% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -99.96% |
| AZTR | Azitra Inc | $3.32M | -99.96% |
| GRI | GRI Bio Inc | $3.30M | -99.96% |
| SPRC | SciSparc Ltd | $3.05M | -99.96% |
| AFMD | Affimed N.V. | $2.98M | -99.96% |
| CMND | Clearmind Medicine Inc | $2.88M | -99.96% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -99.96% |
| ARTL | Artelo Biosciences Inc | $2.75M | -99.96% |
| OGEN | Oragenics Inc | $2.58M | -99.97% |
| PPCB | Propanc Biopharma Inc | $2.50M | -99.97% |
| NTBL | Notable Labs Inc Ord | $2.39M | -99.97% |
| BBLG | Bone Biologics Corp | $2.23M | -99.97% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -99.97% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -99.97% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -99.97% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -99.98% |
| ONCO | Onconetix Inc | $1.61M | -99.98% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -99.98% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -99.98% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -99.98% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -99.98% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -99.98% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -99.98% |
| JAGX | Jaguar Health Inc | $1.34M | -99.98% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -99.98% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -99.99% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -99.99% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -99.99% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -99.99% |
| ELAB | PMGC Holdings Inc | $221376.00 | -100.00% |
| ADTX | Aditxt Inc | $132564.52 | -100.00% |
| CDT | CDT Equity Inc | $110551.31 | -100.00% |